CytRx Calls for Removal of Stock from Berlin-Bremen Exchange
CytRx said this week that it has sent a formal demand letter to the Berlin-Bremen Stock Exchange requesting that the exchange delist the company’s common stock. According to CytRx, its stock was put on the exchange without its permission.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.